research

The United Health Foundation recently released their first-ever comprehensive report on the health of America’€™s senior population. According to a statement from the authors Reed Tuckson, MD and Rhonda Randall, DO , ’€œThe report provides a comprehensive analysis of senior population health rankings on both national and state levels, and it comes at a critical time. Americans are living longer but sicker lives, and America’€™s senior population is poised to grow 53 percent between 2015 and 2030.’€ This fascinating report ranks each state by the incidence of several factors, including obesity, physical inactivity, low-care nursing, and food insecurity. The United Health Foundation, a...
Dr. Wallace H. Coulter Coulter. Medical diagnostics. See a link? Coulter is one-half of Beckman Coulter, a Research!America member and a company that boasts nearly $6 billion in market capitalization . And that half of a multi-billion-dollar, multinational company began with research on paint for the U.S. Navy. Such unlikely beginnings are the reason that Wallace Coulter has been named the first recipient of the Golden Goose Award for 2013 . More winners will be named during the coming months. The press release announcing the award explains Coulter’€™s research: In his time away from working for various electronics companies in the 1940s, Coulter built a lab in his garage and earned a grant...
By Frederick Rivara, MD, MPH. Rivara is President of Society for Advancement of Violence and Injury Research (SAVIR). Dr. Rivara holds the Children’s Guild Association Endowed Chair in Pediatrics, and is a University of Washington professor of pediatrics and an adjunct professor of epidemiology. He is also Editor of JAMA Pediatrics. Frederick Rivara, MD, MPH More than 400 public health researchers and practitioners participated in the 2013 National Meeting of the Society for Advancement of Violence and Injury Research (SAVIR) and Safe States Alliance . Hosted in Baltimore by the Johns Hopkins Center for Injury Research and Policy , this event focused on how research and practice have...
Dear Research Advocate: According to our new national public opinion poll on clinical trials and related topics, most Americans are willing to share their personal health data to advance research, and 72% would be willing to participate in a clinical trial if recommended by their doctor. This complements what we know from other polling, i.e. that Americans want research to proceed at a pace of scientific opportunity. Yet we continue to lose ground in the gridlocked political environment, which, by its inaction, is dashing the hopes of patients and families anxious for new therapies and cures. What’€™s wrong with this picture? It isn’€™t as though research hasn’€™t yielded both societal and...
Dear Research Advocate: I invite you to join me in speaking out during the Memorial Day congressional recess (May 27-31) as part of a social media campaign using the hashtag #curesnotcuts. Our goal is to continue to position research and innovation to improve health where it belongs: as a fundamental national priority that Americans can count on because their elected representatives rank it so highly. In our social media campaign, each day of the recess has a specific theme that can be customized with your information and patient/researcher stories. We have made it easy to get involved: click here to see sample social media messages, a list of selected congressional offices and their...
Dear Research Advocate, House of Representatives Science Committee Chair Lamar Smith’€™s (R-TX) proposed legislation, the “ High Quality Research Act ,” would undermine, rather than achieve, “high quality” in research, since it would create several new hoops for approval of NSF-funded grants. These appear to be based on the mistaken idea that science follows a linear path to a single metric for success or failure. And the bill requires the NSF director to attest in advance to the success of each funded proposal! Letters penned by former NSF directors and National Science Board chairs and former NSF assistant directors warn of the “chilling and detrimental impact” this legislation could have...
Dear Research Advocate, President Obama spoke to the National Academies of Science on Monday. I commend his remarks to you. He charged the members of the Academy, and by extension the science community writ large, to engage at ’€œthe center and the heart of our public debate.’€ He said that IF scientists do so, the nation will be assured of continued prominence. IF is a tall order — it makes most scientists very uncomfortable, but it is essential that we get out of our comfort zone right now. The president didn’€™t pound his fist on the podium in stressing this, so I will. The science community simply cannot step away from the public and political fray right now; not if we want to see the...
Dear Research Advocate, Senators Casey (D-PA) and Burr (R-NC), recently honored with our Whitehead Award for Research Advocacy, have joined forces again with a bipartisan letter calling for a strong commitment to NIH funding in FY 14. Please take a moment now to urge your senators to sign on to this letter. And say thank you to Senators Burr and Casey for being champions for research! In past letters, I’€™ve written about attempts by Congress to micromanage and in some cases, attack critical components of our nation’€™s research portfolio. The social sciences have been targeted time and time again despite the immense value of these programs and the return on investment they represent. In...
Last week, the Wall Street Journal reported that a Nepalese man detained at the U.S.-Mexico border has extremely drug-resistant tuberculosis, XDR-TB. Tuberculosis, a potentially fatal disease that can be passed through the air, has historically been curable with appropriate treatment. However, new strains of TB that are resistant to available drugs have recently emerged and pose a significant public health threat. Some strains are resistant to only a few drugs (multi-drug resistant TB) while other strains, such as the one carried by the man in this story, are resistant to nearly all existing drugs. Because of this, XDR-TB is extremely difficult to treat and experts warn that new drugs will...
Just released data from the White House Office of Management and Budget (OMB) details the final amount to be cut from federal research program budgets as sequestration goes into effect. The full details are available on the updated Research!America sequestration fact sheet , though previous projections were relatively accurate as compared to these final numbers. Cuts to the Centers for Disease Control and Prevention and the Food and Drug Administration will be higher than previously expected, with a combined loss of $593 million dollars for FY13. That amount is roughly equivalent to ensuring the safety of new medical and biological products at the FDA and programs that focus on prevention...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor